← Back to headlines
Cullinan to Present Zipalertinib Trial Results
Biotech company Cullinan is scheduled to discuss clinical trial results for its drug zipalertinib on Monday, providing updates on its pipeline development.
10 Sept, 17:04 — 10 Sept, 17:04
Sources
Showing 1 of 1 sources
Related Stories
Elon Musk Condemns New Documentary as 'Hit Piece' and Threatens Legal Action
45m ago
UAE Announces $46 Billion Investment Plan to Strengthen Economic Ties with Germany
47m ago
TTM Technologies Prices $500 Million Senior Notes
1h ago
Adobe Beats Q3 Revenue Estimates Despite Wall Street Demand for More AI Growth
1h ago